- Home
- SHLT vs CCEL Comparison
SHLT vs CCEL Comparison
Compare SHLT & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- CCEL
- Stock Information
- Founded
- SHLT 1987
- CCEL 1989
- Country
- SHLT Israel
- CCEL United States
- Employees
- SHLT N/A
- CCEL N/A
- Industry
- SHLT Business Services
- CCEL Managed Health Care
- Sector
- SHLT Consumer Discretionary
- CCEL Health Care
- Exchange
- SHLT Nasdaq
- CCEL Nasdaq
- Market Cap
- SHLT 46.9M
- CCEL 50.0M
- IPO Year
- SHLT N/A
- CCEL 1997
- Fundamental
- Price
- SHLT $2.34
- CCEL $7.71
- Analyst Decision
- SHLT Strong Buy
- CCEL
- Analyst Count
- SHLT 1
- CCEL 0
- Target Price
- SHLT $11.00
- CCEL N/A
- AVG Volume (30 Days)
- SHLT 3.3K
- CCEL 15.0K
- Earning Date
- SHLT 09-26-2024
- CCEL 04-14-2025
- Dividend Yield
- SHLT N/A
- CCEL 3.11%
- EPS Growth
- SHLT N/A
- CCEL N/A
- EPS
- SHLT N/A
- CCEL N/A
- Revenue
- SHLT $55,939,000.00
- CCEL $31,838,476.00
- Revenue This Year
- SHLT N/A
- CCEL $3.97
- Revenue Next Year
- SHLT N/A
- CCEL $0.91
- P/E Ratio
- SHLT N/A
- CCEL N/A
- Revenue Growth
- SHLT N/A
- CCEL 1.95
- 52 Week Low
- SHLT $2.03
- CCEL $4.47
- 52 Week High
- SHLT $7.96
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- SHLT 37.15
- CCEL 48.98
- Support Level
- SHLT $2.24
- CCEL $7.26
- Resistance Level
- SHLT $2.40
- CCEL $8.20
- Average True Range (ATR)
- SHLT 0.14
- CCEL 0.54
- MACD
- SHLT -0.02
- CCEL -0.02
- Stochastic Oscillator
- SHLT 37.85
- CCEL 34.15
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.